Business
Brooks Automation Reports Results of First Quarter of Fiscal 2020, Ended December 31, 2019, and Announces Quarterly Cash Dividend
CHELMSFORD, Mass., Feb. 6, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS), a leader in automation solutions for the semiconductor manufacturing
About this update from Azenta, Inc.
[{"type":"text","content":"CHELMSFORD, Mass., Feb. 6, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS), a leader in automation solutions for the semiconductor manufacturing and life sciences industries, today reported financial results for the first fiscal quarter of 2020, ended December 31, 2019.\nFinancial Results Summary\nQuarter Ended\nDollars in millions, except per share data\nDecember 31, \nSeptember 30,\nDecember 31, \nChange vs.\n2019\n2019\n2018\nPrior Qtr\nPrior Year\nRevenue\n$\n210\n$\n199\n$\n179\n6\n%\n17\n%\nSemiconductor Solutions Group\n$\n119\n$\n105\n$\n113\n13\n%\n5\n%\nLife Sciences \n$\n92\n$\n94\n$\n67\n(3)\n%\n38\n%\nDiluted EPS Continuing Operations\n$\n0.18\n$\n0.07\n$\n0.09\n150\n%\n106\n%\nDiluted EPS Total\n$\n0.18\n$\n5.68\n$\n0.20\n(97)\n%\n(11)\n%\nNon-GAAP Diluted EPS Cont. Operations\n$\n0.23\n$\n0.23\n$\n0.17\n(3)\n%\n37\n%\nManagement Comments\n\"The results of our first fiscal quarter of 2020 showed good growth in each segment and we are solidly on track for a strong year,\" commented Steve Schwartz, CEO of Brooks Automation. \"Our Semiconductor Solutions business was lifted by another record quarter of revenue from Contamination Control Solutions, we delivered another quarter of gross margin improvement in Life Sciences Sample Management, and we had strong cash flow from operations.\" \nSummary of GAAP Results for Continuing Operations\nRevenue of $210 million grew 17% year-over-year and diluted EPS from continuing operations was $0.18, which has doubled from $0.09 in the first quarter of 2019. Life Sciences revenue of $92 million grew 38% year-over-year, helped by the acquisition and continued growth of GENEWIZ, which was acquired on November 15, 2018. The organic growth of GENEWIZ was 22% and for Sample Management 3%, year-over-year. Semiconductor Solutions revenue of $119 million grew 5% year-over-year and 13% sequentially, driven by strong shipments of Contamination Control Solutions to end-user fabs and vacuum robots to OEM customers. GAAP operating income was $11 million, compared to $5 million in the first quarter of 2019. The increase was driven by the growth and expanded operating margins in Life Sciences. Life Sciences margins benefited from 340 basis points expansion of gross margins in Sample Management and improved mix from a full quarter of the higher margin results of GENEWIZ compared to a h...